Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ; and Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.
Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ; and Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.
Adv Chronic Kidney Dis. 2018 Mar;25(2):121-132. doi: 10.1053/j.ackd.2017.10.011.
The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.
糖尿病的患病率在全球范围内不断上升,低收入和中等收入国家的增幅最大。在大多数发达国家,2 型糖尿病目前是终末期肾病的主要病因,也是心血管疾病的主要病因。在经济实力较弱的国家,2 型糖尿病正迅速取代传染病,成为导致肾病的主要原因,并越来越多地争夺有限的医疗保健资源。在这里,我们对全球糖尿病相关肾病的患病率和发病率进行了叙述性综述。还将探讨患有糖尿病和肾病患者的死亡率。鉴于慢性肾脏病相关的高发病率和死亡率,我们还将检查患有这种疾病的人的知晓率。